BCL2L1 and cancer: Cancer cells would activate the NF-κB pathway to up-regulate the expression of anti-apoptotic genes, such as c-IAP-1, c-IAP-2, Bcl-Xl, Gadd45β, and Survivin, to avoid apoptosis.